See All AI raises $33M to advance its AI platform that generates 3D surgical images from 2D fluoroscopic X-rays, potentially reducing reliance on pre-op CT and MRI scans.
Key Details
- 1See All AI secured $33 million in funding for its imaging AI platform.
- 2The system converts 2D C-arm fluoroscopic X-rays into 'navigable' 3D volumes.
- 3Aims to reduce the need for pre-operative CT and MRI imaging.
- 4Platform is designed to support minimally invasive surgery workflows.
- 5Technology is not yet FDA-cleared or available clinically; U.S. approval sought this year.
- 6Cadaver studies show capability for high-resolution, cross-plane, 1 mm 3D slices.
Why It Matters
If successful, this technology could streamline surgical planning and reduce costs, radiation, and time in the operating room. It highlights growing industry investment and innovation aimed at augmenting or replacing traditional radiology workflows in perioperative imaging.
Source
Radiology Business
Related News
•AuntMinnie
Deep Learning AI Outperforms Radiologists in Detecting ENE on CT
A deep learning tool, DeepENE, exceeded radiologist performance in identifying lymph node extranodal extension in head and neck cancers using preoperative CT scans.
•Radiology Business
FDA Clears Multi-Disease AI Screening Platform for CT Imaging
HeartLung Corporation's AI-CVD platform receives FDA clearance to detect multiple diseases from a single CT scan.
•AuntMinnie
XGBoost Outperforms Logistic Regression for Lung Cancer Risk Prediction
XGBoost-based lung cancer risk prediction model shows greater accuracy than logistic regression in a large screening cohort.